---
title: Doctors Almost Never Prescribe Opioid Cough Syrup to Children Anymore
description: Opioid cough syrup for children has all but disappeared, now about 4 in 10,000 pediatric visits, capping a long shift in pediatric medicine.
author: Dr Marina Nani (Editor-in-Chief)
date: 2026-08-26T17:30:00.000Z
updated: 2026-08-26T19:01:41.326Z
canonical: https://richhealthmagazine.com/article/opioid-cough-syrup-children-nearly-vanished
image: https://cdn.nanimediahouse.com/pexels-a-caring-mother-pours-medicine-for-her-sick-child-sitting-on-5858836.jpg
categories: Everyday Wellness
content_type: News
region: United States
publication: Rich Health Magazine
schema_type: Article
---

A generation ago, a child with a nagging cough might have left the doctor's office with a bottle of codeine or hydrocodone syrup. That prescription has now nearly disappeared. About 4 in every 10,000 pediatric office visits for a cough or respiratory infection end with an opioid cough medicine, roughly 0.04% of them, according to Motive Medical Intelligence, a healthcare-data firm that examined more than 100 million US insurance claims filed between October 2022 and September 2024.

The rarity holds coast to coast. In Nevada and Vermont, the firm's analysis found not a single such prescription across the two-year window. Wyoming ranked highest at about 1%, a rate Motive said was not statistically different from the national figure. "This is welcome news," said Dr. Rich Klasco, the firm's chief medical officer. "For decades, opioid cough medicines were prescribed to children despite limited evidence of benefit and very real safety concerns."

## The Drugs Were Never Shown to Help a Child's Cough

A Cochrane systematic review found no randomized trials supporting codeine's effectiveness for cough in children, and [no evidence that it works better than placebo](https://pmc.ncbi.nlm.nih.gov/articles/PMC6457872/). Unease inside pediatrics ran back years. The American Academy of Pediatrics warned against pediatric codeine in guidance first issued in 1997 and reaffirmed in 2006, then published a paper titled "Codeine: Time to Say No" in 2016. A codeine cough syrup for a child was already a hard sell among many pediatricians long before any federal action.

## Federal Regulators Restricted the Drugs in 2017 and 2018

The government followed the shift rather than starting it. On April 20, 2017, the FDA contraindicated codeine, along with tramadol, for children under 12. On January 11, 2018, it required labeling changes that limited codeine and hydrocodone cough-and-cold medicines to adults 18 and older. By then, prescribing was already dropping steeply. Codeine prescriptions to US children fell 90.1%, from 232,140 to 23,008, between 2014 and 2019, while hydrocodone fell 75.7%, from 132,501 to 32,232, according to a study in JAMA Network Open.

"The important story here isn't just that prescribing declined," Klasco said. "It's that a deeply entrenched clinical practice can change."

## FAQ

**Q: What safety risks led regulators to restrict these medicines?**
The medicines carry a risk of seriously slowed breathing in children, which can be hard to predict because some children break codeine down into morphine unusually fast. That danger sat against little proven benefit, and that balance drove the FDA's limits.

**Q: Does this mean opioid cough medicine is banned for children?**
Not exactly. The medicines were never pulled from the market. They were restricted and labeled for adults, and pediatricians largely stopped reaching for them, so a child today is very unlikely to be prescribed one even though a blanket ban was never the mechanism.